Article Text


Statistics from

Purpose: The objective of this request for applications (RFA) is to support research that will advance the development of vaccines, adjuvants, therapeutics, immunotherapeutics, and diagnostics that are specific for National Institute of Allergy and Infectious Diseases (NIAID) Category A, B, or C priority pathogens or toxins. Research is not required to result in a “final” product but must advance the development of a candidate product.

A second objective of this RFA is to stimulate scientifically sound, original, and innovative research requiring a comprehensive team and multidisciplinary effort …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.